Vita Coco (COCO) CCO sells 2,000 shares under Rule 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Vita Coco Company, Inc. Chief Commercial Officer Charles van Es reported an open-market sale of 2,000 shares of common stock at $57.98 per share on March 16, 2026. The filing notes these sales were effected under a Rule 10b5-1 trading plan.
After the transaction, van Es directly holds 79,691 shares of common stock. He also holds several non-qualified stock options to buy additional Vita Coco shares, including grants exercisable at $10.178 per share expiring on February 10, 2030 and January 11, 2031, and higher-priced options expiring through March 4, 2035.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 2,000 shares ($115,960)
Net Sell
9 txns
Insider
van Es Charles
Role
Chief Commercial Officer
Sold
2,000 shs ($116K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 2,000 | $57.98 | $116K |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
Holdings After Transaction:
Common Stock — 79,691 shares (Direct);
Non-Qualified Stock Option (Right to Buy) — 53,750 shares (Direct)
Footnotes (1)
- The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. The stock option is fully vested and currently exercisable. The stock option vests in four equal annual installments beginning on November 27, 2022. The stock option vests in three equal annual installments beginning on August 15, 2025. The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026. The stock options vest in four annual equal installments beginning on March 10, 2024. The stock option vests in four equal annual installments beginning on March 4, 2025. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
FAQ
What insider transaction did Vita Coco (COCO) report for Charles van Es?
Vita Coco’s Chief Commercial Officer Charles van Es reported an open-market sale of 2,000 common shares. The shares were sold at $57.98 each on March 16, 2026, according to a Form 4 insider trading disclosure filed with regulators.
Was the Vita Coco (COCO) insider sale by Charles van Es made under a Rule 10b5-1 plan?
Yes. A footnote states the sales of Vita Coco common stock were effected under a Rule 10b5-1 trading plan. Such plans are pre-arranged trading programs that schedule transactions in advance, helping separate routine diversification from discretionary market-timing decisions.
What stock options in Vita Coco (COCO) does Charles van Es hold according to the filing?
The filing shows multiple non-qualified stock options on Vita Coco common stock held by Charles van Es. These include options exercisable at $10.178, $15.00, $15.36, $16.91, $26.18, and $33.36 per share, with expiration dates running from 2030 through 2035.
Did Charles van Es exercise any Vita Coco (COCO) stock options in this Form 4?
No option exercises are reported in this Form 4; only an open-market sale of 2,000 common shares appears. The derivative section lists his existing stock option holdings and vesting details but does not show transactions coded as option exercises on March 16, 2026.